Activated microglia do not mediate the early deposition of Aβ in carriers of the apolipoprotein Eε4 allele

Clinical Neuropathology

Volumn 21, Issue 3, 2002, Pages 99-106

  Vogelgesang, S ^a   Schroeder, E ^a   Walker, L C ^a   Pahnke, J ^a   Naubereit, A ^a   Walther, R ^a   Stausske, D ^a   Warzok, R W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CADAVER; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROGLIA; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; CELL COUNT; FEMALE; GENOTYPE; HUMANS; MALE; MICROGLIA; MIDDLE AGED; SENILE PLAQUES; SEX FACTORS;

EID: 0036251556     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein
2. Early and rapid de novo synthesis of Alzheimer βA4-amyloid precursor protein (APP) in activated microglia
3. Key factors in Alzheimer's disease: Beta-amyloid precurser protein processing, metabolism and intraneural transport
4. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
5. Anti-inflammatory drugs protect against Alzheimer disease at low doses
6. Morphometric analysis of microglia in Alzheimer's disease
7. HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease
8. The pathogenesis of senile plaques
9. Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy
10. Microglial activation in Alzheimer disease: Association with ApoE genotype
11. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precurser protein
12. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease
13. Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms
14. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
15. Epidemiology of dementia and Alzheimer disease
16. Expression of apolipoprotein E mRNA in rat microglia
17. Role of microglia in senile plaque formation
18. Nonsteroidal antiinflammatory drug use and Alzheimer-type pathology in aging
19. Anti-inflammatory drugs and Alzheimer-type pathology in aging
20. Microglial cells and amyloid β protein (Aβ) deposition: Association with Aβ40-containing plaques
21. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
22. Microglia in degenerative neurological disease
23. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
24. Aging, neurodegenerative disease and the brain
25. Role of inflammatory processes and microglial activation in Alzheimer disease
26. Activation of microglial cells by beta-amyloid protein and interferon-gamma
27. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude
28. Reactive microglia in aging and dementia: An immunohistochemical study of postmortem human brain tissue
29. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells
30. Glial cells in Alzheimer's disease: Preferential effect of APOE risk on scattered microglia
31. Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease
32. Microglial interleukin-I alpha expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution
33. Association of microglia with amyloid plaques in brains of APP23 transgenic mice
34. Reactive microgliosis
35. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease
36. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
37. Microglial activation resulting from CD40-CD40L interaction after (beta)-amyloid stimulation
38. Progression of neurofibrillary changes and PHF-τ in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology
39. Inflammatory markers in chronic neurodegenerative disorders with emphasis on Alzheimer's disease
40. Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly
41. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly
42. Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are the leading factor in plaque degradation
43. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice